Original Article

You have full text access to this OnlineOpen article

Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the rat

  1. W Jager,
  2. O Winter,
  3. B Halper,
  4. A Salamon,
  5. M Sartori,
  6. L Gajdzik,
  7. G Hamilton,
  8. G Theyer,
  9. J Graf,
  10. T Thalhammer

Article first published online: 30 DEC 2003

DOI: 10.1002/hep.510260613

Issue

Hepatology

Hepatology

Volume 26, Issue 6, pages 1467–1476, December 1997

Additional Information

How to Cite

Jager, W., Winter, O., Halper, B., Salamon, A., Sartori, M., Gajdzik, L., Hamilton, G., Theyer, G., Graf, J. and Thalhammer, T. (1997), Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: Implications of genistein metabolism in the rat. Hepatology, 26: 1467–1476. doi: 10.1002/hep.510260613

Author Information

  1. Institute of Pharmaceutical Chemistry, Vienna, Austria

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (305K)

References

  • 1
    Elferink RPJ Oude, Meijer DKF, Kuipers F, Jansen PLM, Groen AK, Groothuis GMM. Hepatobiliary secretion of organic compounds; molecular mechanism of membrane transport. Biochim Biophys Acta 1995; 124: 215–268.
  • 2
    Wehner F, Kinne RK-H, Petzinger E. Second international Ringberg conference: “Cell biology and molecular basis of liver transport.”. Hepatology 1996; 24: 259–267.
  • 3
    Keppler D, Arias IM. Hepatic canalicular membrane: Introduction: Transport across the hepatocyte canalicular membrane. FASEB J 1997; 11: 15–18.
  • 4
    Arias IM, Che M, Gatmaitan Z, Leveille C, Nishida T, Pierre M St. The biology of the bile canaliculus. Hepatology 1993; 12: 318–329.
    Direct Link:
  • 5
    Smit JJM, Schinkel AH, Elferink RPJ Oude, Groen AK, Wagenaar E, Van Demeter L, Mol CAAM, et al. Disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and liver disease. Cell 1993; 75: 451–462.
  • 6
    Beukeveld GJ, In-'t-veld G, Havinga R, Groen AK, Wolthers BG, Kuipers F. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport. J Hepatol 1996; 24: 343–352.
  • 7
    Gottesman M, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385–427.
  • 8
    Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, et al. Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 1992; 258: 1650–1654.
  • 9
    Muller M, Meijer C, Zaman GJR, Borst P, Scheper RJ, Mulder NH, De Vries EGE, et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugates. J Biol Chem 1994; 269: 13033–13037.
  • 10
    Leier I, Jedlitschky G, Buchholz SPC, Cole SPC, Deeley RG, Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 1994; 269: 27807–27810.
  • 11
    Jedlitschky G, Leier I, Buchholz SPC, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by MRP gene-encoded conjugate export pump. Cancer Res 1996; 56: 988–994.
  • 12
    Saptarshi P, Breuninger LM, Tew KD, Shen H, Kruh GD. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specifity transporter. Proc Natl Acad Sci USA 1996; 93: 6929–6934.
  • 13
    Mayer R, Kartenbeck J, Büchler M, Jedlitschky G, Leier I, Keppler D. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport deficient hepatocytes. J Cell Biol 1995; 131: 137–150.
  • 14
    Jansen PLM, Peters WH, Lamers W. Hereditary chronic conjugated hyperbilirubinemia in mutant rats caused by defective hepatic anion transport. Hepatology 1985; 5: 573–579.
    Direct Link:
  • 15
    Kartenbeck J, Leuschner U, Mayer R, Keppler D. Absence of the canalicular isoform of the MRP gene encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology 1996; 23: 1061–1066.
  • 16
    Büchler M, König J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic rats. J Biol Chem 1996; 271: 15091–15098.
  • 17
    Paulusma CC, Bosnia PJ, Zaman GJR, Bakker CTM, Otter M, Scheffer GL, Scheper RJ, et al. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 1996; 271: 1126–1128.
  • 18
    Barrand MA, Rhodes T, Center MS, Twentyman PR. Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190 kD membrane protein distinct from p-glycoprotein. Eur J Cancer 1993; 29A: 408–415.
  • 19
    Versantvoort CHM, Schuurhuis GJ, Pinedo HM, Eekman CA, Kuiper CM, Lankelma J, Broxterman HJ. Genistein modulates the decreased drug accumulation in non-P-Glycoprotein mediated multidrug resistant tumour cells. Br J Cancer 1993; 68: 939–946.
  • 20
    Takeda Y, Nishio K, Niitani H, Saijo N. Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multi-drug-resistant cell line. Int J Cancer 1994; 57: 229–239.
    Direct Link:
  • 21
    Feller N, Kuiper CN, Lankelma J, Ruhdal JK, Scheper RJ, Pinedo HM, Broxterman HJ. Functional detection of MDR1/p170 and MRP/P190-mediated multidrug resistance in tumor cells by flow cytometry. Br J Cancer 1995; 72: 543–549.
  • 22
    Castro AF, Altenberg GA. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-Glycoprotein. Biochem Pharmacol 1997; 53: 89–93.
  • 23
    Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592–5595.
  • 24
    Thalhammer T, Stapf V, Gadzik L, Graf J. Bile canalicular cationic dye secretion as a model for P-glycoprotein mediated transport. Eur J Pharmacol 1994; 270: 213–220.
  • 25
    Braakman I, Groothuis GMM, Meijer DKF. Acinar redistribution and heterogeneity in transport of the organic cation rhodamine B in rat liver. Hepatology 1987; 7: 849–855.
    Direct Link:
  • 26
    Stapf V, Thalhammer T, Huber-Huber R, Felberbauer F, Gajzik L, Graf J. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of P-glyoprotein mediated transport in liver. Anticancer Res 1994; 14: 581–586.
  • 27
    Vilstrup H, Keiding S, Vendsborg PB. Kinetics of galactose uptake by perfused rat livers: applicability of a family of models. J Theor Biol 1983; 101: 335–344.
  • 28
    Frei J, Schmid E, Birchmeier H. UDP-glucuronyl-transferase. In: BergmeierHU, ed. Methoden der enzymatischen Analyse. Weinheim, Germany: Verlag Chemie Weinheim, 1970.
  • 29
    Jansen PL, Van-Klinken JW, Van-Gelder M, Ottenhof R, Elferink RP. Preserved organic anion transport in mutant TR- rats with a hepatobili-ary secretion defect. Am J Physiol 1993; 265: G445–G452.
  • 30
    Smith RL. The Excretory Function of Bile. The elimination of drugs and toxic substances in bile. London: Chapman and Hall, 1973.
  • 31
    Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125: 777–783.
  • 32
    Yasuda T, Mizunuma S, Kano Y, Saito KI, Ohsawa K. Urinary and biliary metabolites of genistein in rats. Biol Pharm Bull 1996; 19: 413–417.
  • 33
    Saptarshi P, Breuninger LM, Kruh G. ATP-dependent transport of lipophilic cytotoxic drugs by membrane vesicles prepared from MRP-over-expressing HL60/ADR cells. Biochemistry 1996; 35: 14003–14011.
  • 34
    Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab Dispos 1996; 24: 232–237.
  • 35
    Burchell B. Molecular biology of the uridine diphophate glucuronyl-transferases. In: TavoloniN, BerkPD, eds. Hepatic Transport and Bile Secretion: Physiology and Pathophysiology. New York: Raven, 1993: 489–499.
  • 36
    Versantvoort CH, Broxterman HJ, Lankelma J, Feller N, Pinedo HM. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 1994; 48: 1129–1136.
  • 37
    Chieli E, Romiti N, Cervelli F, Tongiani R. Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci 1995; 57: 1741–175.
  • 38
    Steen H, Smit H, Nijholt A, Merema M, Meijer DKF. Modulators of the protein kinase C system influence biliary excretion of cationic drugs. Hepatology 1993; 18: 1208–1215.
    Direct Link:
  • 39
    Roelofson HR, Ottenhof R, Schoemaker B, Jansen PLM, Elferink RPJ Oude Hepatocanalicular organic-anion transport is regulated by protein kinase C. Biochem J 1991; 278: 637–641.
  • 40
    Noe B, Schliess F, Wettstein M, Heinrich S, Haussinger D. Regulation of taurocholate excretion by a hypo-osmotic-activated signal transduction pathway in rat liver. Gastroenterology 1996; 110: 858–865.
  • 41
    German UA, Chamber TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I, Gottesman M. Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 1996; 271: 1708–1716.
  • 42
    Sargeant P, Farndale RW, Sage SO. ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem 1993; 268: 18151–18156.
Get PDF (305K)